Penserra Capital Management LLC Grifols Sa Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.21 - $15.27 $27,158 - $40,618	-2,660 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$14.07 - $17.3 $844 - $1,038	-60 Reduced 2.21%	2,660 $38,000
Q2 2021 Aug 12, 2021	BUY	$16.62 - $18.94 $581 - $662	35 Added 1.3%	2,720 $47,000
Q1 2021 May 13, 2021	SELL	$15.15 - $19.78 $833 - $1,087	-55 Reduced 2.01%	2,685 $46,000
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $28,088 - $32,770	1,666 Added 155.12%	2,740 $50,000
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $16,539 - $21,651	1,074 New	1,074 $18,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.